Clear Rock Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$2.55M Buy
4,701
+242
+5% +$128K 1.09% 35
2024
Q1
$2.31M Buy
4,459
+109
+3% +$54.2K 1% 34
2023
Q4
$2.2M Buy
+4,350
New +$2.01M 1% 35

Other funds holding ELV

Clear Rock Advisors's ELV Position: Q2 2024 in Review

Clear Rock Advisors increased its Elevance Health (ELV) stake by 5.4% in Q2 2024, buying an estimated $128K and bringing the position to 4,701 shares worth $2.55M. The position accounts for 1.09% of the portfolio, ranked #35.

Clear Rock Advisors first reported a position in ELV in Q4 2023 and has held it in 3 quarters since. 1,705 funds tracked by Wall St. Rank hold ELV as of Q2 2024.

  • Clear Rock Advisors held 4,701 shares of Elevance Health worth $2.55M as of Q2 2024.
  • Clear Rock Advisors bought 242 Elevance Health shares in Q2 2024, an estimated $128K.
  • Elevance Health made up 1.09% of Clear Rock Advisors's portfolio in Q2 2024, its #35 holding.
  • Clear Rock Advisors first reported a position in Elevance Health in Q4 2023 and has held it in 3 quarters since.
  • 1,705 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.

Based on Clear Rock Advisors's 13F filing for Q2 2024, filed 3 Sep 2024.